Inventor · disambiguated record
Thierry Guyon
Also filed as: GUYON THIERRY
14 granted patents·12 pending applications·195 citations·filing 2003–2012
94Inventor score
Files withGANTIER RENE9GUYON THIERRY5HANALL BIOPHARMA CO LTD4BORRELLY GILLES1CATALYST BIOSCIENCES INC1
Top patents by PatentIndex Score
26 records- 0194US7650243B2Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid moleculesHANALL PHARMACEUTICAL CO LTD·Filed 2007·Granted Jan 19, 2010·39 cites·19 claims
- 0292US7998469B2Protease resistant interferon beta mutantsHANALL BIOPHARMA CO LTD·Filed 2007·Granted Aug 16, 2011·14 cites·11 claims
- 0392US7611700B2Protease resistant modified interferon alpha polypeptidesHANALL PHARMACEUTICALS CO LTD·Filed 2003·Granted Nov 3, 2009·34 cites·24 claims
- 0491US8052964B2Interferon-β mutants with increased anti-proliferative activityHANALL BIOPHARMA CO LTD·Filed 2008·Granted Nov 8, 2011·11 cites·12 claims
- 0590US7884073B2Modified growth hormoneHANALL BIOPHARMA CO LTD·Filed 2006·Granted Feb 8, 2011·14 cites·32 claims
- 0689US8383388B2Modified coagulation factor IX polypeptides and use thereof for treatmentCATALYST BIOSCIENCES INC·Filed 2007·Granted Feb 26, 2013·22 cites·65 claims
- 0789US7998930B2Modified growth hormonesHANALL BIOPHARMA CO LTD·Filed 2005·Granted Aug 16, 2011·13 cites·12 claims
- 0887US8222209B2Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereofGUYON THIERRY·Filed 2011·Granted Jul 17, 2012·12 cites·17 claims
- 0986US8252743B2Modified erythropoietin polypeptides and uses thereof for treatmentGUYON THIERRY·Filed 2007·Granted Aug 28, 2012·16 cites·27 claims
- 1084US8057787B2Protease resistant modified interferon-beta polypeptidesGANTIER RENE·Filed 2008·Granted Nov 15, 2011·4 cites·13 claims
- 1184US7635679B2Protease resistant mutant of human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A)CREABILIS THERAPEUTICS SPA·Filed 2007·Granted Dec 22, 2009·11 cites·3 claims
- 1282US8114839B2Protease resistant modified erythropoietin polypeptidesGANTIER RENE·Filed 2008·Granted Feb 14, 2012·3 cites·23 claims
- 1378US8105573B2Protease resistant modified IFN beta polypeptides and their use in treating diseasesGANTIER RENE·Filed 2011·Granted Jan 31, 2012·2 cites·4 claims
- 1464US2008159977A1Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid moleculesGANTIER RENE·Filed 2007·Application pending·0 cites
- 1563US2008194477A1Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid moleculesGANTIER RENE·Filed 2007·Application pending·0 cites
- 1663US2008075672A1Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid moleculesGANTIER RENE·Filed 2007·Application pending·0 cites
- 1762US2007254838A1Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid moleculesGANTIER RENE·Filed 2007·Application pending·0 cites
- 1859US2005202438A1Rational directed protein evolution using two-dimensional rational mutagenesis scanningFiled 2003·Application pending·0 cites
- 1959US2006020116A1Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid moleculesGANTIER RENE·Filed 2005·Application pending·0 cites
- 2056US8058232B2HMGB1 high affinity binding domain Box-A mutantsFUMERO SILVANO·Filed 2009·Granted Nov 15, 2011·0 cites·5 claims
- 2152US2008003202A1Modified interferon-beta (IFN-beta) polypeptidesGUYON THIERRY·Filed 2007·Application pending·0 cites
- 2252US2008038224A1Modified interferon-beta (IFN-beta) polypeptidesGUYON THIERRY·Filed 2007·Application pending·0 cites
- 2349US2012264686A9Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereofGUYON THIERRY·Filed 2009·Application pending·0 cites
- 2449US2006020396A1Rational directed protein evolution using two-dimensional rational mutagenesis scanningGANTIER RENE·Filed 2005·Application pending·0 cites
- 2544US2013243855A1Modified coagulation factor IX polypeptides and use thereof for treatmentOYHENART JORGE·Filed 2012·Application pending·0 cites
- 2643US2006251619A1Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptidesBORRELLY GILLES·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →